X. PGC-1␣ attenuates neointimal formation via inhibition of vascular smooth muscle cell migration in the injured rat carotid artery. Am J Physiol Cell Physiol 297: C645-C653, 2009. First published June 24, 2009 doi:10.1152/ajpcell.00469.2008.-Oxidative stress contributes significantly to the migration of vascular smooth muscle cells (VSMCs), the major pathogenic process of vascular diseases, but the mechanism remains unclear. In the present study, we explored the role of peroxisome proliferator-activated receptor-␥ coactivator-1␣ (PGC-1␣), a major regulator of mitochondrial biogenesis and energy balance, in VSMC migration in vitro and in vivo. Overexpression of PGC-1␣ in cultured VSMCs led to a 74.5% reduction of migration activity and mitochondrial ROS generation by the increased expression of antioxidative proteins such as SOD-2 in the mitochondria. The knockdown of PGC-1␣ by specific small interfering (si)RNA markedly augmented VSMC migration activity and greatly reduced mitochondrial antioxidative protein expression. Furthermore, knockdown of SOD-2 expression by siRNA greatly reversed the inhibitory effect of PGC-1␣ overexpression on VSMC migration. In a rat carotid balloon injury model, adenovirus-mediated overexpression of PGC-1␣ greatly reduced neointimal formation (ratio of intima to media: 0.78 Ϯ 0.09 vs. 1.45 Ϯ 0.18 in the adenovirus ϩ green fluorescent protein genetransfected group). Moreover, the expression of SOD-2 was significantly increased in vivo in local vessels after injury in the PGC-1␣-overexpressing group. These data strongly suggest that PGC-1␣ inhibits VSMC migration and neointimal formation after vascular injury in rats, mainly by upregulating the expression of the mitochondrial antioxidant enzyme SOD-2. restenosis; antioxidants; smooth muscle cells; metabolic syndrome; peroxisome proliferator-activated receptor-␥ coactivator-1␣ VASCULAR SMOOTH MUSCLE CELL (VSMC) proliferation and migration are characteristic features of various vascular diseases such as atherosclerosis and neointimal hyperplasia after vascular intervention (6,28). Increased oxidative stress in VSMCs plays an important role in the pathogenesis of atherosclerosis and neointima formation (3,20). Genetic and pharmacological inhibition of ROS-generating systems can ameliorate atherosclerosis and neointimal hyperplasia after vascular injury in animal models (20,34).Peroxisome proliferator-activated receptor (PPAR)-␥ coactivator (PGC)-1␣, originally identified as a transcriptional coactivator of PPAR-␥ (30), is a central regulator of lipid catabolism and mitochondrial number and function (9). PGC-1␣ is abundantly expressed in tissues and cells with high metabolic rates, such as brown adipose tissue (35), skeletal muscle (7,23,25), the liver (33), the heart (2), and the brain (11). Our studies and those of others have demonstrated that PGC-1␣ is also expressed in vascular cells, especially in VSMCs (17, 40) and endothelial cells (ECs) (17,36), but the role of PGC-1␣ in vascular cells remains ambiguous. We have previously demon...